ACTIVATE

Start now with an ACC (CardioSource) login, or register for access today.

GO

Clinical Toolkits

These easy-to-use tools will help you to implement guidelines-based and best practice care, and address common clinical issues at your facility.

  • QI Toolkit

    Implement quality patient care at your facility with checklists, reminders, and other tools to address common quality improvement issues.

  • Public Reporting Toolkit

    Implement best practices for improving data collection processes, overall data quality through better registry data capture, and performance on publicly reported metrics.

  • Bleeding Risk Checklist

    Implement tools to decrease the risk of bleeding complications after percutaneous coronary procedures.

  • H2H Toolkits

    Implement tools designed to help facilities improve care transitions from hospital to "home" and reduce risk of federal penalties associated with high readmission rates

  • Surviving MI Toolkit

    Implement tools to lower 30-day risk stratified mortality rates and improve organizational culture for patients hospitalized with AMI.

  • QI Tools for Outpatient Practices

    Practices participating in the PINNACLE Registry can implement these tools to improve quality in their facilities, in the areas  of early follow up, patient education, communication and stroke prevention.

  • ACC Guideline Clinical App

    Download this free mobile app to access clinical guideline content and tools for clinicians caring for patients with cardiovascular disease.

  • ACC Statin Intolerance App

    Download this free mobile app to access clinical guideline content and tools for clinicians managing and treating patients who report muscle symptoms while on statin therapy.

  • ASCVD Risk Estimator

    Download this free mobile app to access guideline reference information for both providers and patients related to therapy, monitoring, and lifestyle.

  • AnticoagEvaluator App

    Download this easy and fast tool to assess stroke and bleeding risk in patients at your facility, and identify the benefits and risks of antithrombotic therapy in patients with non-valvular chronic atrial fibrillation.